NovoQuantNexus
NovoQuantNexus offers an AI-powered platform for parallel drug discovery, combining molecular intelligence with orchestration capabilities to rapidly identify compliant, licensable drug candidates. Their platform features QuantaMCP for managed discovery campaigns, ADDIE Design Studio for molecule generation and evaluation, Nexus Property Graph for enrichment with ADMET and safety signals, FAVES Guardian for embedded safety and regulatory checks, an Executive Command Console for visibility, and Nexus Connect for integration with existing systems. NovoQuantNexus aims to deliver defensible outcomes by enabling discovery, prioritization, safeguarding, and delivery of drug candidates.
NovoQuantNexus
NovoQuantNexus offers an AI-powered platform for parallel drug discovery, combining molecular intelligence with orchestration capabilities to rapidly identify compliant, licensable drug candidates. Their platform features QuantaMCP for managed discovery campaigns, ADDIE Design Studio for molecule generation and evaluation, Nexus Property Graph for enrichment with ADMET and safety signals, FAVES Guardian for embedded safety and regulatory checks, an Executive Command Console for visibility, and Nexus Connect for integration with existing systems. NovoQuantNexus aims to deliver defensible outcomes by enabling discovery, prioritization, safeguarding, and delivery of drug candidates.